Steve Persaud, MD, PhD

While I have mixed feelings about being back on Twitter, I have nothing but pride for this paper, my first mentee @AdityaYelamali 's first first author paper and my first paper as senior author. Glad to have found a good home for this study in Blood ICT @BloodPortfolio

Proud to amplify this study from Seung Kim’s lab about using antibody conditioning and JAK inhibition for allo-HSCT/tolerance induction for islet transplantation to treat NOD diabetes. Also grateful to have been able to write a short article about it with @Dipersiolab

Curing autoimmune diabetes in mice! Preksha Bhagchandani @prekshab17 et al. @StanfordMed present a clinically translatable, low toxicity conditioning regimen in combination with hematopoietic cell and islet transplantation that reverses established type 1 diabetes in mice: jci.org/articles/view/… The image: Histology of the recovered islet graft in diabetic mice that received allogeneic hematopoietic cell and islet transplantation shows intact B6 islets with few CD45+ immune cells 20 weeks after transplantation.